BioMarin amends bylaws to adopt majority voting for directors and tighten advance notice provisions

BIOMARIN PHARMACEUTICAL INC

Uncontested director elections now require 'for' votes to exceed 'against' votes (majority voting standard).
Advance notice deadlines clarified; stockholder must appear at meeting or proposal is disregarded.
Stockholders must update disclosure information as of record date and 10 days before meeting.
Company may request information on nominee independence; substitute nominees require full disclosure.
Officers may be removed by majority of directors present at a meeting with a quorum.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BIOMARIN PHARMACEUTICAL INC: Approved and adopted Amended and Restated Bylaws, effective February 25, 2025, with updates to advance notice provisions, director election standards, officer removal, and administrative updates (effective 2025-02-25).

Change: bylaw amendment
Effective: 2025-02-25

Exact text from the filing

On February 25, 2025, the Board of Directors (the "Board") of BioMarin Pharmaceutical Inc. (the "Company") approved and adopted the Company's Amended and Restated Bylaws (as so amended, the "Amended Bylaws"), effective as of February 25, 2025.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

BIOMARIN PHARMACEUTICAL INC filing history →

Source: SEC EDGAR

accession 0001193125-25-044103

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.